MedMen Reports 55% Year-Over-Year Quarterly Revenue Growth and Second Consecutive Quarter of Growth in Both Revenue and Retail Adjusted EBITDA

Stock Information for MedMen Enterprises Inc - Class B (Sub Voting)

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MedMen Enterprises Inc - Class B (Sub Voting)

MedMen Announces Management and Board Changes
Canadian Investment Regulatory Organization Trading Halt - MMEN
MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis
MedMen Provides Annual Filing Status Report
MedMen Enters into Definitive Agreements to Exit Arizona and Nevada per Announced Strategic Review, Selling Non-Core Assets to MINT Cannabis
MedMen Provides Annual Filing Status Report
MedMen Provides Annual Filing Status Report
MedMen Announces Delay of Filing of Financial Statements for the Year Ended July 1, 2023 and Issuance of Management Cease Trade Order

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.